echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Plant Extracts News > In three years, the total output of the whole country will reach 40000 tons

    In three years, the total output of the whole country will reach 40000 tons

    • Last Update: 2014-02-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    According to Yubo Zhiye Market Research Center, the price of Panax notoginseng has declined since last year The unit price in January this year was 600 yuan, compared with more than 800 yuan in the same period last year, with a year-on-year decrease of nearly 30% The decrease of 37 price will help to reduce the cost pressure of Kunming Pharmaceutical and Zhongheng group "The large number of listings in the third and seventh quarter of last year has led to the situation that supply exceeds demand in the current market From the perspective of national planting area and market demand, the total output of the country in three years will reach 40000 tons, while the market demand is only about 20000 tons In the next two or three years, the price of the country is likely to keep a downward trend " This person said to reporters In the view of Zhongheng group, the company currently has a planting area of 3000 mu in 1-3 years The company's 37 main root consumption is about 600 tons "From the situation in 2013, thanks to the 37 price reduction, Zhongheng group's operating cost will be saved by 120 million yuan, equivalent to 22% of the total operating cost in 2012." Some brokers predicted this to reporters "If there is no abnormal drought in 2014, the supply will still be far greater than the demand Therefore, this year's March 7th price decline is more likely The gross margin of the company's main products will be significantly improved " In terms of Kunming Pharmaceutical, in 2013, about 320 tons of Panax notoginseng were used, of which more than 50% were used to produce lyophilized Xuesaitong, about 30% were used to produce Xuesaitong Soft Capsule, and the consumption of water needle accounted for about 20% Company sources told reporters that the 37 price drop will help reduce the company's costs However, he also pointed out that some varieties with weak bargaining power, such as Xuesaitong tablet and Shuizhen, will also decline in the downstream market due to the decline in the price of raw materials Relevant Chinese Medicine Research Report 2014-2017 market prospect analysis and Investment Development Planning Research Report 2014-2020 market investigation and Investment Value Analysis Research Report 2013-2016 market depth investigation and investment strategy research of Jilin Chinese medicine injection industry 2013-2016 Jilin Chinese medicine injection industry depth Research Report 2013-2016 Market Research Report of medicine injection industry more analysis of medicine industry If you want to master the latest report, please refer to 2012-2016 Market Research and trend forecast report of Chinese medicine industry.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.